Internal Medicine, Hematology & Oncology · Highland Park, IL
NPI
1184767444
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
767 Park Ave W, Suite 120
Highland Park, IL, 60035
Phone (847) 432-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,319 services
Medicare patients, 2024
386
Average age 76
Drug cost, 2024
$3.2M
1,150 prescriptions
Company payments, 2025
$36.03
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adi Gidron was code 99214 (office e&m - established), 452 times for 141 patients. In total Adi Gidron billed 1,319 services in 14 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 452 | 141 | $73.30 | $33K |
| 99213 Office E&M - Established | Facility | 235 | 159 | $46.76 | $11K |
| 99214 Office E&M - Established | Office | 209 | 90 | $75.93 | $16K |
| 99231 Hospital E&M - Subsequent | Facility | 116 | 58 | $40.65 | $4,716 |
| 99213 Office E&M - Established | Office | 92 | 67 | $51.30 | $4,719 |
| 99232 Hospital E&M - Subsequent | Facility | 77 | 31 | $63.75 | $4,909 |
| 99223 Hospital E&M - Initial | Facility | 62 | 56 | $137.83 | $8,546 |
| 99204 Office E&M - New | Facility | 25 | 25 | $103.11 | $2,578 |
| 99203 Office E&M - New | Facility | 14 | 14 | $54.78 | $767 |
By year: 2022 $115K for 1,589 services; 2023 $117K for 1,700 services; 2024 $90K for 1,319 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adi Gidron prescribed most often to Medicare patients was Hydroxyurea, with 71 prescriptions and refills. In total Adi Gidron wrote 1,150 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 71 | 145 | 20 | $1,630 |
| Letrozole Generic | 71 | 195 | 23 | $1,706 |
| Valacyclovir Valacyclovir Hcl | 68 | 195 | 22 | $4,110 |
| Eliquis Apixaban | 63 | 114 | 15 | $63K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 58 | 58 | 12 | $1,215 |
| Brukinsa Zanubrutinib | 47 | 47 | Under 11 | $697K |
| Dexamethasone Generic | 46 | 56 | 19 | $517 |
| Deferasirox Generic | 38 | 38 | Under 11 | $9,992 |
| Hydromorphone Hcl Generic | 27 | 27 | Under 11 | $229 |
| Xtandi Enzalutamide | 23 | 23 | Under 11 | $314K |
| Ondansetron Odt Ondansetron | 23 | 23 | 17 | $294 |
| Furosemide Generic | 22 | 34 | Under 11 | $153 |
| Anastrozole Generic | 20 | 52 | Under 11 | $208 |
| Warfarin Sodium Generic | 20 | 51 | Under 11 | $365 |
| Allopurinol Generic | 20 | 40 | Under 11 | $154 |
Brand drugs: 295 claims; generic drugs: 855 claims; opioid claims: 118.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adi Gidron $36.03 ($36.03 in general payments such as food, travel and fees) from 2 companies. The largest payer was Daiichi Sankyo Inc. with $19.49.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 1 | $19.49 |
| Melinta Therapeutics, LLC | 1 | $16.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.